GSK wins Illinois Zantac court battle
GSK PLC (LSE:GSK, NYSE:GSK) has successfully refuted claims that its discontinued heartburn drug Zantac caused cancer after an Illinois jury…
17,008€
-0,85%
Echtzeit-Aktienkurs GSK PLC
Bid:
Ask:
Nachrichten zur GSK PLC Aktie
GSK wins Illinois court battle
GSK PLC (LSE:GSK, NYSE:GSK) has successfully refuted claims that its discontinued heartburn drug Zantac caused cancer after an Illinois jury…
GSK cancer drug receives expanded approval from the US regulator
The US Food and Drug Administration (FDA) has expanded the approval of GSK PLC (LSE:GSK, NYSE:GSK)’s Jemperli (dostarlimab) in combination…
GSK sees £1.2bn wiped from its value as investors grumble about vaccine miss
Around £1.2 billion was wiped from the value of GSK PLC (LSE:GSK, NYSE:GSK) after the drug giants Q2 vaccine sales…
GSK: Impfstoffsegment enttäuscht - Aktienanalyse
Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…
GSK verdient operativ mehr und erhöht Jahresziele - Aktie dennoch im Minus
LONDON (dpa-AFX) - Beim Pharmakonzern GSK laufen die Geschäfte weiterhin rund. Für das Gesamtjahr hob…
GSK forecast upgrade fails to impress the market
GSK PLC (LSE:GSK, NYSE:GSK) has raised its annual earnings and sales forecasts after a strong second-quarter performance driven by cancer…
GSK reaches confidential settlement in Illinois
GSK PLC (LSE:GSK, NYSE:GSK) said it has reached a confidential settlement with Ronald Kimbrow resolving the case he filed in Illinois…
GSKs vaccine receives positive European Medicines Agency opinion
GSK PLCs (LSE:GSK, NYSE:GSK) respiratory syncytial virus vaccine, Arexvy, has received a positive opinion from the European Medicines Agencys Committee...…
Merz will europäische Pharmaindustrie stärken
DRESDEN (dpa-AFX) - Der CDU-Bundesvorsitzende Friedrich Merz will die Wettbewerbsfähigkeit der europäischen Pharmaindustrie stärken. Es brauche…
GSK downgraded by UBS over vaccine concerns, Zantac litigation
UBS analysts have downgraded GSK PLC (LSE:GSK, NYSE:GSK) from a buy to neutral rating, citing uncertainties surrounding its vaccine portfolio and...…
ANALYSE-FLASH: UBS senkt GSK auf 'Neutral' - Ziel runter auf 1580 Pence
ZÜRICH (dpa-AFX) - Die Schweizer Großbank UBS hat GSK von "Buy" auf "Neutral" abgestuft und…
Global Herpes Treatment Market Size To Worth USD 1.87 Billion By 2033 | CAGR Of 4.28%
The Global Herpes Treatment Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Herpes Treatment Market…
GSK takes full control of flu vaccine programme in €1.45bn deal
GSK PLC (LSE:GSK, NYSE:GSK) said it will take effective control of a collaboration to create new mRNA vaccines for influenza and…
GSK and Moderna RSV vaccine sell-off is overdone, say analysts
After GSK PLC (LSE:GSK, NYSE:GSK) shares fell sharply on the back of US authorities restricting doses of respiratory syncytial virus (RSV)…
GSK and Moderna slide on RSV vaccine CDC updates
GSK PLC (LSE:GSK, NYSE:GSK) shares fell 6% after US authorities recommended restrictions on doses of any respiratory syncytial virus (RSV) vaccine.…
GSK plummets as US restricts RSV vaccine
GSK PLC (LSE:GSK, NYSE:GSK) is attempting to drive the FTSE 100 lower after it plunged close to 7% following a…
GSK plunges as US restricts RSV vaccine
GSK PLC (LSE:GSK, NYSE:GSK) shares plunged close to 7% following a ruling in the US that is likely to restrict…
GSK plunges as US restricts RSV vaccine
GSK PLC (LSE:GSK, NYSE:GSK) shares plunged close to 7% following a ruling in the US that is likely to restrict…
GSK 100% backs London listing, says boss
GSK PLC (LSE:GSK, NYSE:GSK) has issued its support to the flagging London market, stating that it is “unequivocally, 100 per cent…
GSK still appealing despite US legal setback says broker
GSK PLC (LSE:GSK, NYSE:GSK) is still appealing - even in the wake of a significant legal setback, according to regional…
GSK appeals Delaware Zantac ruling
GSK PLC (LSE:GSK, NYSE:GSK) and other pharmaceutical companies asked a Delaware court to allow an appeal of a ruling permitting…
GSK RSV jab receives label expansion from US regulator
GSK PLC (LSE:GSK, NYSE:GSK) has confirmed that the US Food & Drug Administration has approved Arexvy for preventing respiratory syncytial…
GSK: Still reasons to be cheerful rather than fearful after nightmare Monday
What was supposed to be a stellar day for GSK PLC (LSE:GSK, NYSE:GSK) at the annual American Society of Clinical…
GSK-Aktie stürzt nach Gerichtsurteil ab - Aktienanalyse
Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…
GSK: Zantac-Klagen - Belastungen in Milliardenhöhe? Aktienanalyse
Kulmbach (www.aktiencheck.de) - GSK-Aktienanalyse von "Der Aktionär":
Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von GSK plc (ISIN: GB00BN7SWP63,…
GSK: Zantac litigation obscures the positives, says leading investment bank
Deutsche Bank has maintained its "buy" rating on GSK PLC (LSE:GSK, NYSE:GSK) despite the recent setback in the Zantac litigation as…
GSK: Zantac litigation obscures the positives, says leading investment bank
Deutsche Bank has maintained its "buy" rating on GSK PLC (LSE:GSK, NYSE:GSK) despite the recent setback in the Zantac litigation as…
GSK to appeal US judges Zantac ruling
GSK PLC (LSE:GSK, NYSE:GSK) says it disagrees with a decision by a court judge in the US state of Delaware who…
GSK shares plunge after US judge rules Zantac cases can go ahead
GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…
GSK shares plunge after US judge rules Zantac cases can go to trial
GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…
GSK to appeal US judges Zantac ruling, shares plunge
GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…
GSK shares plunge after US judge rules Zantac cases can go to trial
GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…
GSK plc: Long-Term Cash Cow
…
GSK found not guilty in Zantac trial
British pharmaceuticals big cap GSK PLC (LSE:GSK, NYSE:GSK) has won a high-stake personal injury case in the state of Illinois,…
GSK found not guilty in Zantac trial
British pharmaceuticals big cap GSK PLC (LSE:GSK, NYSE:GSK) has won a high-stake personal injury case in the state of Illinois,…
GSK: Zantac settlement could reach $2bn, says investment bank
GSK PLC (LSE:GSK, NYSE:GSK) may face a settlement of up to $2 billion to resolve thousands of lawsuits related to…
GSK: Moderate Bewertung trotz Kursanstieg - Aktienanalyse
Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), stuft die…
GSK confirms Haleon exit for total of £3.9 billion
GSK PLC (LSE:GSK, NYSE:GSK) confirmed it has raised a total of £3.9 billion through the exit of its stake in…
GSK confirms exit of Haleon stake for £3.9 billion
GSK PLC (LSE:GSK, NYSE:GSK) confirmed it has raised a total of £3.9 billion through the exit of its stake in…
GSK plc (GSK) Q1 2024 Earnings Call Transcript
…
GSK beginning to alleviate long-held concerns, say analysts
GSK PLC (LSE:GSK, NYSE:GSK) is approaching 18-month highs after the pharma groups boss Emma Walmsley raised the full-year outlook on the…
Pharmahersteller GSK erhöht Gewinnziel für 2024
LONDON (dpa-AFX) - Der Pharmakonzern GSK ist besser als erwartet in das neue Jahr gestartet.…
ANALYSE-FLASH: Jefferies belässt GSK auf 'Buy' - Ziel 1950 Pence
NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die Einstufung für GSK auf "Buy"…
ROUNDUP: Pharmahersteller GSK will auch 2024 mehr verdienen - Aktie legt zu
LONDON (dpa-AFX) - Der Pharmakonzern GSK rechnet nach einem Ergebnis- und Umsatzplus im vergangenen Jahr…
Pharmahersteller GSK will auch 2024 mehr verdienen - optimistischer für Zukunft
LONDON (dpa-AFX) - Der Pharmakonzern GSK rechnet nach einem Ergebnis- und Umsatzplus im vergangenen Jahr…
ANALYSE-FLASH: Jefferies hebt GSK auf 'Buy' und Ziel auf 1900 Pence
NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat GSK von "Hold" auf "Buy" hochgestuft und…
ANALYSE-FLASH: Jefferies hebt GSK auf 'Buy' und Ziel auf 1900 Pence
NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat GSK von "Hold" auf "Buy" hochgestuft und…
ANALYSE-FLASH: Jefferies senkt Ziel für GSK auf 1550 Pence - 'Hold'
NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für GSK von 1650…
ANALYSE-FLASH: JPMorgan hebt Ziel für GSK auf 1400 Pence - 'Underweight'
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für GSK nach Zahlen…